UA112433C2 - Короткочасний вплив рослинних полісахаридів на пізнавальну здатність та настрій у здорової людини - Google Patents
Короткочасний вплив рослинних полісахаридів на пізнавальну здатність та настрій у здорової людиниInfo
- Publication number
- UA112433C2 UA112433C2 UAA201312473A UAA201312473A UA112433C2 UA 112433 C2 UA112433 C2 UA 112433C2 UA A201312473 A UAA201312473 A UA A201312473A UA A201312473 A UAA201312473 A UA A201312473A UA 112433 C2 UA112433 C2 UA 112433C2
- Authority
- UA
- Ukraine
- Prior art keywords
- mood
- acid
- cognition
- short
- healthy human
- Prior art date
Links
- 230000036651 mood Effects 0.000 title abstract 2
- 230000019771 cognition Effects 0.000 title 1
- 150000004676 glycans Chemical class 0.000 title 1
- 229920001282 polysaccharide Polymers 0.000 title 1
- 239000005017 polysaccharide Substances 0.000 title 1
- 235000013311 vegetables Nutrition 0.000 title 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 abstract 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 abstract 2
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 abstract 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 abstract 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 abstract 2
- 235000015872 dietary supplement Nutrition 0.000 abstract 2
- 239000008103 glucose Substances 0.000 abstract 2
- 208000019901 Anxiety disease Diseases 0.000 abstract 1
- AEMOLEFTQBMNLQ-YMDCURPLSA-N D-galactopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-YMDCURPLSA-N 0.000 abstract 1
- AEMOLEFTQBMNLQ-AQKNRBDQSA-N D-glucopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-AQKNRBDQSA-N 0.000 abstract 1
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 abstract 1
- PNNNRSAQSRJVSB-SLPGGIOYSA-N Fucose Natural products C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C=O PNNNRSAQSRJVSB-SLPGGIOYSA-N 0.000 abstract 1
- SHZGCJCMOBCMKK-DHVFOXMCSA-N L-fucopyranose Chemical compound C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 abstract 1
- 208000019914 Mental Fatigue Diseases 0.000 abstract 1
- SQVRNKJHWKZAKO-PFQGKNLYSA-N N-acetyl-beta-neuraminic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)O[C@H]1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-PFQGKNLYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 abstract 1
- 150000001412 amines Chemical class 0.000 abstract 1
- 230000036506 anxiety Effects 0.000 abstract 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 abstract 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 abstract 1
- SQVRNKJHWKZAKO-UHFFFAOYSA-N beta-N-Acetyl-D-neuraminic acid Natural products CC(=O)NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO SQVRNKJHWKZAKO-UHFFFAOYSA-N 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 150000001720 carbohydrates Chemical class 0.000 abstract 1
- 230000003930 cognitive ability Effects 0.000 abstract 1
- 229930182830 galactose Natural products 0.000 abstract 1
- 229940097043 glucuronic acid Drugs 0.000 abstract 1
- 230000013016 learning Effects 0.000 abstract 1
- 230000035882 stress Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7012—Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical, e.g. glucuronic acid, neuraminic acid
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7008—Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L21/00—Marmalades, jams, jellies or the like; Products from apiculture; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/322—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the nervous system or on mental function
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/328—Foods, ingredients or supplements having a functional effect on health having effect on glycaemic control and diabetes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/60—Sugars, e.g. mono-, di-, tri-, tetra-saccharides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Mycology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Diabetes (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Psychology (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Винахід стосується способу покращення пізнавальної здатності, настрою, здатності до навчання, пам'яті, або зниження стресу, тривоги, розумового стомлення, або будь-яких комбінацій зазначеного, у здорової людини, що передбачає застосування дієтичної добавки, яка містить дієтологічно ефективну кількість виділеної та очищеної ацетильованої манози та дієтологічно ефективну кількість щонайменше п'яти виділених та очищених сахаридів, вибраних з-посеред галактози, глюкози, манози, ксилози, N-ацетилнейрамінової кислоти, фукози, N-ацетилгалактозаміну, N-ацетилілюкозаміну, арабінози, глюкуронової кислоти, галактуронової кислоти, ідуронової кислоти й арабіногалактану, причому дієтична добавка не спричинює в здорової людини зростання рівня глюкози в крові.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161479632P | 2011-04-27 | 2011-04-27 | |
| PCT/US2012/034752 WO2012148887A2 (en) | 2011-04-27 | 2012-04-24 | Acute cognitive and mood effects of plant polysaccharides in adult human subjects |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA112433C2 true UA112433C2 (uk) | 2016-09-12 |
Family
ID=47068083
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAA201312473A UA112433C2 (uk) | 2011-04-27 | 2012-04-24 | Короткочасний вплив рослинних полісахаридів на пізнавальну здатність та настрій у здорової людини |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20120276208A1 (uk) |
| EP (1) | EP2701711B1 (uk) |
| JP (3) | JP6254937B2 (uk) |
| KR (5) | KR102516683B1 (uk) |
| AU (2) | AU2012249967A1 (uk) |
| CA (1) | CA2834042C (uk) |
| ES (1) | ES2833081T3 (uk) |
| MX (1) | MX2013012449A (uk) |
| PE (2) | PE20181047A1 (uk) |
| SG (2) | SG194608A1 (uk) |
| UA (1) | UA112433C2 (uk) |
| WO (1) | WO2012148887A2 (uk) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20120276208A1 (en) * | 2011-04-27 | 2012-11-01 | University Of South Australia | Acute cognitive and mood effects of plant polysaccharides in adult human subjects |
| GB201305708D0 (en) * | 2013-03-28 | 2013-05-15 | Clasado Inc | Novel use |
| WO2017023703A1 (en) * | 2015-07-31 | 2017-02-09 | Sivanaray, Inc. | Compounds, compositions and methods for prevention or treatment of liver and lipid-related conditions |
| CA3030809A1 (en) | 2016-07-28 | 2018-02-01 | Fonterra Co-Operative Group Limited | Sialyloligosaccharide product and process |
| EP3568139A4 (en) * | 2017-01-13 | 2020-10-28 | Sivanaray, Inc. | COMPOUNDS, COMPOSITIONS AND PROCEDURES FOR THE PREVENTION OR TREATMENT OF LIVER AND LIPID RELATED DISEASES |
| WO2018156513A1 (en) * | 2017-02-21 | 2018-08-30 | Sivanaray Inc. | Compounds, compositions and methods for prevention or treatment of liver, lipid, and glucose-related conditions |
| WO2020033502A1 (en) * | 2018-08-08 | 2020-02-13 | Neuro Biofuels Limited | Methods for treatment of brain injury and brain dysfunction |
| EP4304044A1 (en) | 2021-11-02 | 2024-01-10 | Lg Energy Solution, Ltd. | Power storage source management apparatus and control method therefor |
| US11883457B1 (en) * | 2022-09-06 | 2024-01-30 | Optigenex Inc. | Method of enhancing cognition in individuals with at least normal cognition |
| CN115317507A (zh) * | 2022-09-19 | 2022-11-11 | 中国科学院海洋研究所 | 低分子量褐藻多糖硫酸酯在制备抗多动症药物中的应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6929807B1 (en) | 1996-08-09 | 2005-08-16 | Mannatech, Inc. | Compositions of plant carbohydrates as dietary supplements |
| BR9711054B1 (pt) * | 1996-08-09 | 2011-10-18 | composição de suplemento dietético para fornecer sacarìdeos de produtos nutritivos. | |
| US20120276208A1 (en) * | 2011-04-27 | 2012-11-01 | University Of South Australia | Acute cognitive and mood effects of plant polysaccharides in adult human subjects |
-
2012
- 2012-04-23 US US13/453,540 patent/US20120276208A1/en not_active Abandoned
- 2012-04-24 JP JP2014508477A patent/JP6254937B2/ja active Active
- 2012-04-24 AU AU2012249967A patent/AU2012249967A1/en not_active Abandoned
- 2012-04-24 ES ES12776559T patent/ES2833081T3/es active Active
- 2012-04-24 KR KR1020217038790A patent/KR102516683B1/ko active IP Right Grant
- 2012-04-24 KR KR1020137031566A patent/KR20140041503A/ko active Application Filing
- 2012-04-24 PE PE2018000279A patent/PE20181047A1/es unknown
- 2012-04-24 EP EP12776559.2A patent/EP2701711B1/en active Active
- 2012-04-24 CA CA2834042A patent/CA2834042C/en active Active
- 2012-04-24 PE PE2013002406A patent/PE20140869A1/es not_active Application Discontinuation
- 2012-04-24 KR KR1020187017974A patent/KR20180073718A/ko active Application Filing
- 2012-04-24 SG SG2013078951A patent/SG194608A1/en unknown
- 2012-04-24 KR KR1020197013846A patent/KR20190055268A/ko not_active IP Right Cessation
- 2012-04-24 UA UAA201312473A patent/UA112433C2/uk unknown
- 2012-04-24 KR KR1020167008979A patent/KR20160043140A/ko active Application Filing
- 2012-04-24 WO PCT/US2012/034752 patent/WO2012148887A2/en active Application Filing
- 2012-04-24 SG SG10201913704RA patent/SG10201913704RA/en unknown
- 2012-04-24 MX MX2013012449A patent/MX2013012449A/es active IP Right Grant
-
2016
- 2016-03-21 AU AU2016201764A patent/AU2016201764A1/en not_active Abandoned
-
2017
- 2017-09-19 JP JP2017179578A patent/JP2018030860A/ja active Pending
-
2020
- 2020-04-10 JP JP2020070727A patent/JP7311114B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US20120276208A1 (en) | 2012-11-01 |
| KR20210149215A (ko) | 2021-12-08 |
| PE20181047A1 (es) | 2018-07-03 |
| WO2012148887A9 (en) | 2012-12-27 |
| KR102516683B1 (ko) | 2023-04-03 |
| KR20180073718A (ko) | 2018-07-02 |
| CA2834042A1 (en) | 2012-11-01 |
| JP7311114B2 (ja) | 2023-07-19 |
| KR20160043140A (ko) | 2016-04-20 |
| AU2012249967A1 (en) | 2013-11-07 |
| CA2834042C (en) | 2018-12-11 |
| AU2016201764A1 (en) | 2016-04-07 |
| NZ616789A (en) | 2016-05-27 |
| EP2701711A4 (en) | 2014-11-05 |
| PE20140869A1 (es) | 2014-08-01 |
| SG194608A1 (en) | 2013-12-30 |
| JP2018030860A (ja) | 2018-03-01 |
| KR20190055268A (ko) | 2019-05-22 |
| MX2013012449A (es) | 2014-04-16 |
| WO2012148887A2 (en) | 2012-11-01 |
| JP2020125312A (ja) | 2020-08-20 |
| JP2014522389A (ja) | 2014-09-04 |
| JP6254937B2 (ja) | 2017-12-27 |
| SG10201913704RA (en) | 2020-03-30 |
| EP2701711A2 (en) | 2014-03-05 |
| EP2701711B1 (en) | 2020-09-30 |
| KR20140041503A (ko) | 2014-04-04 |
| ES2833081T3 (es) | 2021-06-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UA112433C2 (uk) | Короткочасний вплив рослинних полісахаридів на пізнавальну здатність та настрій у здорової людини | |
| PH12017550052A1 (en) | Compostion comprising siallyllactose for use in enhancing learning skills and memory function | |
| MX354875B (es) | Composiciones y métodos para mejorar la función mitocondrial y tratar enfermedades neurodegenerativas y trastornos cognitivos. | |
| WO2009140657A3 (en) | Method of treating chronic heart failure | |
| EP4272839A3 (en) | Treatment of allergic rhinitis using a combination of mometasone and olopatadine | |
| BR112012007502A2 (pt) | método diagnóstico e aparelho para potencial de previsão acuidade visual preservada | |
| Vincent | Serial blood lactate levels reflect both lactate production and clearance | |
| WO2015138773A3 (en) | Optic neuropathy treatment and reduction of steroid-induced oxidative stress with stabilized polyunsaturated substances | |
| BR112018008040A2 (pt) | composição nutricional compreendendo um hidrolisado de caseína, bem como um butirato dietético e/ou um composto para estimular a formação de butirato endógeno | |
| GB2471827B (en) | Treatment of stress | |
| WO2011009757A3 (de) | Verwendung von humanem beta-defensin zur beeinflussung des natürlichen pigmentierungsprozesses | |
| BR112016029749A2 (pt) | composições que compreendem cinamaldeído e zinco e métodos de uso de tais composições | |
| Mostafaie et al. | Comparative survey of depression among chronic disease and healthy adolescences of Hamadan City | |
| ŞENGÜL et al. | Health locus of control beliefs and postural control in chronic low back pain patients | |
| WO2011028797A3 (en) | Treatment of glaucoma and other retinopathies with gangliosides | |
| Hosseinian et al. | Effectiveness of supportive psychotherapy on quality of life of women with HIV in Kermanshah | |
| TH156247A (th) | ส่วนผสมสารสกัดที่อุดมไปด้วยเอลลาจิแทนนิน | |
| Oh et al. | The Effects of Music Intervention upon Lighting on Autonomic Nervous System | |
| Zuybina et al. | ASSESSMENT OF THE STATE OF HEALTH OF CHILDREN, DEPENDING ON THE SOCIO-ECONOMIC LIVING CONDITIONS | |
| Yaguchi | The comprehension of synesthetic expressions with onomatopeic words. | |
| Kampanaros et al. | Conventional and complementary interventions and cognitive performance in old age | |
| Downing | Uneasy beginnings: Getting psychotherapy underway with the difficult patient. | |
| BR112013027616A2 (pt) | Efeitos agudos cognitivos e de humor de polissacarídeos de plantas em individuos humanos adultos | |
| Chopan Zideh et al. | The effect of psychological and educational interventions for child-centered, family-centered and a combination of reduced symptoms of autistic children in real life | |
| Imdad | Laughter-The Best Medicine |